Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 294
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00354172 | Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers. | ||
| NCT03981705 | Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer | ||
| NCT00345865 | Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | ||
| NCT00293293 | Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine | ||
| NCT04928950 | Charcoal in Lung Cancer Patients Undergoing TEMLA | ||
| NCT00305682 | Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant | ||
| NCT01181258 | Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies | ||
| NCT01370213 | NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases | ||
| NCT00617188 | Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer | ||
| NCT04105270 | RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial | ||
| NCT02395822 | MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients | ||
| NCT00619021 | Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer | ||
| NCT00888316 | Iron Overload in Patients Undergoing Donor Stem Cell Transplant | ||
| NCT06692426 | Trial of Cell Based Therapy for DMD | ||
| NCT07493538 | MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases | ||
| NCT06414278 | Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy | ||
| NCT00265863 | Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites | ||
| NCT02845414 | Study of CD133KDEL Toxin in the Treatment for Solid Tumors | ||
| NCT04740008 | Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices | ||
| NCT02582775 | MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs | ||
| NCT01962636 | Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases | ||
| NCT00176865 | Stem Cell Transplant for Immunologic or Histiocytic Disorders | ||
| NCT00726739 | Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma | ||
| NCT07560865 | First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma | ||
| NCT02948062 | Early Diagnosis Of Childhood Cerebral ALD | ||
| NCT00258427 | Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia | ||
| NCT01288222 | Selecting a Favorable KIR Donor in Unrelated HCT for AML | ||
| NCT00963872 | Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer | ||
| NCT00668564 | Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism | ||
| NCT00625092 | Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies | ||
| NCT07910019 | Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background and Addressing Functional Disparities With Trispecific Killer Engagers | ||
| NCT02227797 | MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients | ||
| NCT01343368 | Preservation of Ovarian Function After Hematopoietic Cell Transplant | ||
| NCT00622674 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | ||
| NCT01033552 | Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs | ||
| NCT00177047 | Autologous Transplant for Multiple Myeloma | ||
| NCT01144442 | WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer | ||
| NCT00295880 | Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer | ||
| NCT00769990 | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | ||
| NCT00725062 | Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant | ||
| NCT00287859 | Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | ||
| NCT02141451 | ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL | ||
| NCT01639456 | CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission | ||
| NCT00176891 | Stem Cell Transplant w/Laronidase for Hurler | ||
| NCT00895414 | Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer | ||
| NCT00478244 | Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa | ||
| NCT06584929 | Rural Smoking Cessation | ||
| NCT02118311 | Treg Cells for AGVHD in Non-myeloablative UCB Transplant | ||
| NCT01400672 | Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma | ||
| NCT01705288 | Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study |
